FI CONNECT
GLOBAL
Search
Select Country
LIFE AT FI GROUP
CONTACT
BACK TO TOP
Certifications
Previous slide
Next slide
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group
UK-US pharmaceuticals deal: implications for biotech funding and R&D tax
Help us to share it on
About this publication
Published Date
03-12-2025
Reading Time
16 min.
Author
Dr. Giuseppe Amoroso
Not to be missed
12 hours ago
UKRI’s funding reforms: what they mean for universities, life sciences and advanced engineering
14 hours ago
UK regulatory pathway for drugs manufactured in space: what it means for life sciences companies
a month ago
R&D tax in 2026: a CFO’s compliance playbook
a month ago
UKRI signals tougher choices ahead: what it means for innovation funding strategies
2 months ago
UK R&D Spending Surges in 2025, Led by Pharma and Biotech
All Publications
